series-a
Stage
1
Investors
About
Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation monoclonal and multispecific antibody therapeutics with half-life extension technology to treat severe immune-mediated inflammatory diseases such as atopic dermatitis and inflammatory bowel disease.
Explore Bionyra Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.